Therapeutics and Clinical Management of Neurological Disorders: Exploring Novel Approaches and Biomarkers of Vulnerability

Articles

ORIGINAL RESEARCH

Published on 29 Nov 2024

Overexpression of endothelial S1pr2 promotes blood–brain barrier disruption via JNK/c-Jun/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models

REVIEW

Published on 05 Nov 2024

Progress in GABAA receptor agonists for insomnia disorder

ORIGINAL RESEARCH

Published on 03 Oct 2024

Cathepsins and neurological diseases: a Mendelian randomization study

ORIGINAL RESEARCH

Published on 24 Jun 2024

Dexamethasone alleviates etomidate-induced myoclonus by reversing the inhibition of excitatory amino acid transporters

REVIEW

Published on 24 May 2024

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

ORIGINAL RESEARCH

Published on 25 Mar 2024

Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis

Share on

Frontiers in Pharmacology

Submit your idea

Articles

Overexpression of endothelial S1pr2 promotes blood–brain barrier disruption via JNK/c-Jun/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models

Progress in GABAA receptor agonists for insomnia disorder

Cathepsins and neurological diseases: a Mendelian randomization study

Dexamethasone alleviates etomidate-induced myoclonus by reversing the inhibition of excitatory amino acid transporters

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis

Frontiers in Pharmacology